FDA cleared expansion Enhatch has achieved FDA 510(k) clearance for a patient specific instrumentation system for Total Knee Arthroplasty, signaling regulatory validation and a ready-to-sell orthopedic offering that can accelerate market entry and trust with hospitals and surgeons.

XR and AR capabilities Partnerships and technology focus on extended reality streaming for intraoperative procedures and surgical training, highlighting opportunities to upsell XR-enabled planning and training modules to teaching hospitals and large surgical centers.

Integrated planning platform The AI-powered preoperative planning and scheduling portal with 3D planning, inventory visibility, and stakeholder communication presents cross-sell potential to hospital systems seeking end-to-end operations optimization and last-mile inventory management.

Strategic growth funding Recent growth funding and strategic investments indicate investor confidence and a favorable funding environment; leverage this upside to engage with potential enterprise customers and hospital networks looking for scalable, well-funded software solutions.

Market positioning Operating in a space with peers like Proximie and Oxford Medical Simulation, Enhatch can target mid to large orthopedic centers and academic medical centers with bundled software for surgical planning, scheduling, and XR-enabled training to differentiate from competitors.